CHICAGO--(BUSINESS WIRE)-- Archivel Farma, S.L. has announced that its breakthrough treatment for tuberculosis (TB) will shortly start phase II clinical trials. The treatment uses the company’s unique ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback